Meta-analysis of early versus deferred revascularization for NonST-segment elevation acute coronary syndrome

American Journal of Cardiology

Volumn 108, Issue 9, 2011, Pages 1207-1213

  Zhang, Shuning ^a   Ge, Junbo ^a   Yao, Kang ^a   Qian, Juying ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; CORONARY ARTERY RECANALIZATION; DEATH; DEFERRED CORONARY REVASCULARIZATION; EARLY CORONARY REVASCULARIZATION; EARLY INTERVENTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MEDLINE; META ANALYSIS; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT SAFETY; PRIORITY JOURNAL; RECURRENT DISEASE; REPEAT PROCEDURE; SYSTEMATIC REVIEW;

ACUTE CORONARY SYNDROME; HEMORRHAGE; HUMANS; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 80054698169     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.06.035     Document Type: Article

References (22)

1. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M.F. Piepoli, C. Pirlet, J.L. Pomar, N. Reifart, F.L. Ribichini, M.J. Schalij, P. Sergeant, P.W. Serruys, S. Silber, M. Sousa Uva, and D. Taggart Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
2. J.W. Ryan, E.D. Peterson, A.Y. Chen, M.T. Roe, E.M. Ohman, C.P. Cannon, P.B. Berger, J.F. Saucedo, E.R. DeLong, S.L. Normand, C.V. Pollack Jr, and D.J. Cohen Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry Circulation 112 2005 3049 3057 (Pubitemid 43113435)
3. E. Polverejan, J.C. Gardiner, C.J. Bradley, M. Holmes-Rovner, and D. Rovner Estimating mean hospital cost as a function of length of stay and patient characteristics Health Econ 12 2003 935 947 (Pubitemid 37407338)
4. P. Tricoci Time to coronary angiography in patients with nonST-segment elevation acute coronary syndrome: how fast should patients go to the catheterization laboratory? Curr Opin Cardiol 23 2008 585 590
5. P. Sorajja, B.J. Gersh, D.A. Cox, M.G. McLaughlin, P. Zimetbaum, C. Costantini, T. Stuckey, J.E. Tcheng, R. Mehran, A.J. Lansky, C.L. Grines, and G.W. Stone Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol 55 2010 1416 1424
6. P.A. McCullough, C.M. Gibson, P.M. Dibattiste, L.A. Demopoulos, S.A. Murphy, W.S. Weintraub, F.J. Neumann, S. Khanal, C.P. Cannon TACTICS-TIMI-18 Investigators Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial J Interv Cardiol 17 2004 81 86 (Pubitemid 38648473)
7. N. Swanson, G. Montalescot, K.A. Eagle, S.G. Goodman, W. Huang, D. Brieger, G. Devlin GRACE Investigators Delay to angiography and outcomes following presentation with high-risk, nonST-elevation acute coronary syndromes: results from the Global Registry of Acute Coronary Events Heart 95 2009 211 215
8. R.K. Riezebos, E. Ronner, E. Ter Bals, T. Slagboom, P.C. Smits, J.M. ten Berg, F. Kiemeneij, G. Amoroso, M.S. Patterson, M.J. Suttorp, J.G. Tijssen, G.J. Laarman OPTIMA Trial Immediate versus deferred coronary angioplasty in nonST-segment elevation acute coronary syndromes Heart 95 2009 807 812
9. S.R. Mehta, C.B. Granger, W.E. Boden, P.G. Steg, J.P. Bassand, D.P. Faxon, R. Afzal, S. Chrolavicius, S.S. Jolly, P. Widimsky, A. Avezum, H.J. Rupprecht, J. Zhu, J. Col, M.K. Natarajan, C. Horsman, K.A. Fox, S. Yusuf TIMACS Investigators Early versus delayed invasive intervention in acute coronary syndromes N Engl J Med 360 2009 2165 2175
10. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, D.J. Gavaghan, and H.J. McQuay Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12 (Pubitemid 26120810)
11. A.C. Kalil, M.H. Murthy, E.D. Hermsen, F.K. Neto, J. Sun, and M.E. Rupp Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis Crit Care Med 38 2010 1802 1808
12. J.P. Ioannidis, N.A. Patsopoulos, and E. Evangelou Uncertainty in heterogeneity estimates in meta-analyses BMJ 335 2007 914 916 (Pubitemid 350076978)
13. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
14. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634 (Pubitemid 27387172)
15. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche, J.P. Ioannidis, M. Clarke, P.J. Devereaux, J. Kleijnen, and D. Moher The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 suppl 2009 b2700
16. F.J. Neumann, A. Kastrati, G. Pogatsa-Murray, J. Mehilli, H. Bollwein, H.P. Bestehorn, C. Schmitt, M. Seyfarth, J. Dirschinger, and A. Schömig Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial JAMA 290 2003 1593 1599 (Pubitemid 37441261)
17. A.W. van 't Hof, S.T. de Vries, J.H. Dambrink, K. Miedema, H. Suryapranata, J.C. Hoorntje, A.T. Gosselink, F. Zijlstra, and M.J. de Boer A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study 2b/3a Upstream therapy and acute coronary syndromes Eur Heart J 24 2003 1401 1405 (Pubitemid 36961829)
18. G. Montalescot, G. Cayla, J.P. Collet, S. Elhadad, F. Beygui, H. Le Breton, R. Choussat, F. Leclercq, J. Silvain, F. Duclos, M. Aout, J.L. Dubois-Randé, O. Barthélémy, G. Ducrocq, A. Bellemain-Appaix, L. Payot, P.G. Steg, P. Henry, C. Spaulding, E. Vicaut ABOARD Investigators Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial JAMA 302 2009 947 954
19. K.A. Fox, T.C. Clayton, P. Damman, S.J. Pocock, R.J. de Winter, J.G. Tijssen, B. Lagerqvist, and L. Wallentin Long-term outcome of a routine versus selective invasive strategy in patients with nonST-segment elevation acute coronary syndrome a meta-analysis of individual patient data J Am Coll Cardiol 55 2010 2435 2445
20. P. Damman, A. Hirsch, F. Windhausen, J.G. Tijssen, R.J. de Winter ICTUS Investigators 5-Year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial: a randomized comparison of an early invasive versus selective invasive management in patients with nonST-segment elevation acute coronary syndrome J Am Coll Cardiol 55 2010 858 864
21. B. Lagerqvist, S. Husted, F. Kontny, E. Sthle, E. Swahn, L. Wallentin Fast Revascularisation during InStability in Coronary artery disease (FRISC-II) Investigators 5-Year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in nonST-elevation acute coronary syndrome: a follow-up study Lancet 368 2006 998 1004 (Pubitemid 44353692)
22. K.A. Fox, P. Poole-Wilson, T.C. Clayton, R.A. Henderson, T.R. Shaw, D.J. Wheatley, R. Knight, and S.J. Pocock 5-Year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial Lancet 366 2005 914 920 (Pubitemid 41265665)